Literature DB >> 164119

Granular cell tumor (myoblastoma) of the orbit.

G González-Almaraz, S de Buen, V Tsutsumi.   

Abstract

An 8-year-old white boy had a tumor in the left orbit with clinical manifestations of muscular impairment, exophthalmos, and reduced visual acuity. Five months after exenteration of the orbit the boy was healthy without tumor recurrence. Based on our observations with electron, light, and phase microscopy, and histochemical studies, we conclude that this tumor is benign, of histiocytic origin, and we propose the term granular cell histiocytoma be used to describe this entity.

Entities:  

Mesh:

Year:  1975        PMID: 164119     DOI: 10.1016/0002-9394(75)90800-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  6 in total

1.  Granular cell tumour of the orbit: radiological findings.

Authors:  I Moseley
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

2.  Case report of granular cell myoblastoma arising within the medial rectus muscle.

Authors:  P Moriarty; A Garner; J E Wright
Journal:  Br J Ophthalmol       Date:  1983-01       Impact factor: 4.638

3.  Infiltrating orbital granular cell tumour: a case report and literature review.

Authors:  P J Dolman; J Rootman; C L Dolman
Journal:  Br J Ophthalmol       Date:  1987-01       Impact factor: 4.638

Review 4.  Orbital granular cell tumours: clinical and pathologic characteristics of six cases and literature review.

Authors:  X-F Li; J Qian; Y-F Yuan; Y-W Bi; R Zhang
Journal:  Eye (Lond)       Date:  2016-01-08       Impact factor: 3.775

5.  Surgical Excision of Orbital Progressive Granular Cell Tumour.

Authors:  Demetrio Germanò; Hossein Mostafa Elbadawy; Diego Ponzin; Daniele Ferro; Leonardo Priore
Journal:  Case Rep Ophthalmol Med       Date:  2015-05-18

Review 6.  Paediatric orbital alveolar soft part sarcoma recurrence during long-term follow-up: a report of 3 cases and a review of the literature.

Authors:  Yujiao Wang; Baixue Du; Mei Yang; Weimin He
Journal:  BMC Ophthalmol       Date:  2020-02-21       Impact factor: 2.209

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.